Lower frequency of TLR9 variant associated with protection from breast cancer among African Americans.
Toll-like receptor 9 (TLR9) is an innate immune system DNA-receptor that regulates tumor invasion and immunity in vitro. Low tumor TLR9 expression has been associated with poor survival in Caucasian patients with triple negative breast cancer (TNBC). African American (AA) patients with TNBC have wor...
Main Authors: | Madison R Chandler, Kimberly S Keene, Johanna M Tuomela, Andres Forero-Torres, Renee Desmond, Katri S Vuopala, Kevin W Harris, Nancy D Merner, Katri S Selander |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5590816?pdf=render |
Similar Items
-
Absent Toll-like receptor-9 expression predicts poor prognosis in renal cell carcinoma
by: Paavonen Timo K, et al.
Published: (2011-09-01) -
Toll-like Receptor 9 in Breast Cancer
by: Katri eSelander, et al.
Published: (2014-07-01) -
IRAK4 and TLR3 sequence variants may alter breast cancer risk among African-American women
by: Susan Taylor Yeyeodu, et al.
Published: (2013-10-01) -
Toll-like receptors in esophageal cancer
by: Joonas H Kauppila, et al.
Published: (2014-05-01) -
Culture and Masculinity in American School Shootings: Reviewing Evidence from Multi-Victim School Shootings
by: Keskinen, Katri Ilona Maria
Published: (2018)